"Clinical studies for the advancement of medicine & the improvement of lives. Our core team is exceptional in their field of clinical studies, having a combined 50+ years of experience in conducting clinical trials. We are passionate about the work we do every day. We believe that clinical studies will advance medicine and help people live better lives from the work we are doing. With this mentality, we strive for greatness in each area of work that we do."

During the past decade, Advanced Research for Health Improvement conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 4 clinical trials were completed, i.e. on average, 19% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 4 clinical trials were completed. i.e. 30.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Advanced Research for Health Improvement" #1 sponsor was "Celgene" with 4 trials, followed by "Pfizer" with 3 trials sponsored, "Biohaven Pharmaceuticals, Inc." with 2 trials sponsored, "Amgen" with 1 trials sponsored and "Amneal Ireland Limited" with 1 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Advanced Research for Health Improvement" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator, "Cargill" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "HealthCore-NERI" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Advanced Research for Health Improvement" are "Crohn Disease" (3 trials), "Atherosclerotic Cardiovascular Disease" (2 trials), "COVID-19" (2 trials), "Acute Treatment of Migraine" (1 trials) and "Aging Frailty" (1 trials). Many other conditions were trialed in "Advanced Research for Health Improvement" in a lesser frequency.

Most popular intervention types in "Advanced Research for Health Improvement" are "Drug" (16 trials), "Other" (6 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Ozanimod" (3 trials), "13-valent pneumococcal conjugate vaccine" (1 trials), "20-valent pneumococcal conjugate vaccine" (1 trials) and "Apixaban" (1 trials). Other intervention names were less common.

The vast majority of trials in "Advanced Research for Health Improvement" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Advanced Research for Health Improvement". undefined are not yet recruiting, 10 are recruiting, 2 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 4 completed trials in Advanced Research for Health Improvement, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Advanced Research for Health Improvement, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".